{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:49:04Z","timestamp":1784231344162,"version":"3.55.0"},"reference-count":29,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2018]]},"DOI":"10.7883\/yoken.jjid.2017.233","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T22:09:55Z","timestamp":1509401395000},"page":"8-13","source":"Crossref","is-referenced-by-count":20,"title":["International Comparison of Causative Bacteria and Antimicrobial Susceptibilities of Urinary Tract Infections between Kobe, Japan, and Surabaya, Indonesia"],"prefix":"10.7883","volume":"71","author":[{"given":"Koichi","family":"Kitagawa","sequence":"first","affiliation":[{"name":"Division of Translational Research for Biologics, Department of Internal Related Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Shigemura","sequence":"additional","affiliation":[{"name":"Department of Urology, Kobe University Graduate School of Medicine"},{"name":"Department of International Health, Kobe University Graduate School of Health Science"},{"name":"Department of Infection Control and Prevention, Kobe University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukashi","family":"Yamamichi","sequence":"additional","affiliation":[{"name":"Department of Urology, Hyogo Prefectural Amagasaki General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindawati","family":"Alimsardjono","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Airlangga University\/Dr. Soetomo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dadik","family":"Rahardjo","sequence":"additional","affiliation":[{"name":"Institute of Tropical Disease, Airlangga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuntaman","family":"Kuntaman","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Airlangga University\/Dr. Soetomo Hospital"},{"name":"Department of Internal Medicine, Faculty of Medicine, Airlangga University\/Dr. Soetomo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Shirakawa","sequence":"additional","affiliation":[{"name":"Division of Translational Research for Biologics, Department of Internal Related Medicine"},{"name":"Department of Urology, Kobe University Graduate School of Medicine"},{"name":"Division of Advanced Medical Science, Kobe University Graduate School of Science, Technology and Innovation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Fujisawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49:53-70.","DOI":"10.1067\/mda.2003.7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29:73-9.","DOI":"10.1097\/QCO.0000000000000228"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Flores-Mireles AL, Walker JN, Caparon M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13:269-84.","DOI":"10.1038\/nrmicro3432"},{"key":"4","unstructured":"4. Nozarian Z, Abdollahi A. Microbial etiology and antimicrobial susceptibility of bacteria implicated in urinary tract infection in Tehran, Iran. Iran J Pathol. 2015;10:54-60."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Briongos-Figuero LS, G\u00f3mez-Traveso T, Bachiller-Luque P, et al. Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria. Int J Clin Pract. 2012;66:891-6.","DOI":"10.1111\/j.1742-1241.2012.02991.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Swaminathan S, Alangaden GJ. Treatment of resistant enterococcal urinary tract infections. Curr Infect Dis Rep. 2010;12:455-64.","DOI":"10.1007\/s11908-010-0138-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Choi DM, Heo TH, Yim HE, et al. Evaluation of new American Academy of Pediatrics guideline for febrile urinary tract infection. Korean J Pediatr. 2015;58:341-6.","DOI":"10.3345\/kjp.2015.58.9.341"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rhinehart E, Goldmann DA, O&apos;Rourke EJ. Adaptation of the Centers for Disease Control guidelines for the prevention of nosocomial infection in a pediatric intensive care unit in Jakarta, Indonesia. Am J Med. 1991;91:213S-220S.","DOI":"10.1016\/0002-9343(91)90371-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Oreskovic NM, Sembrano EU. Repeat urine cultures in children who are admitted with urinary tract infections. Pediatrics. 2007;119:e325-9.","DOI":"10.1542\/peds.2006-1134"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shigemura K, Shirakawa T, Okada H, et al. Rapid detection and differentiation of Gram-negative and Gram-positive pathogenic bacteria in urine using TaqMan probe. Clin Exp Med. 2005;4:196-201.","DOI":"10.1007\/s10238-004-0056-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yan Y, Meng S, Bian D, et al. Comparative evaluation of Bruker Biotyper and BD Phoenix systems for identification of bacterial pathogens associated with urinary tract infections. J Clin Microbiol. 2011;49:3936-9.","DOI":"10.1128\/JCM.05363-11"},{"key":"12","unstructured":"12. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disc susceptibility tests 7th ed. Document M2-A7. Wayne, PA: CLSI; 2000."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takaba K, Shigemura K, Osawa K, et al. Emergence of extended-spectrum \u03b2-lactamase-producing <i>Escherichia coli<\/i> in catheter-associated urinary tract infection in neurogenic bladder patients. Am J Infect Control. 2014;42:e29-31.","DOI":"10.1016\/j.ajic.2013.11.018"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yasuda M, Takahashi S, Kiyota H, et al. UTI Subcommittee of the Clinical Evaluation Guidelines Committee. Japanese guideline for clinical research of antimicrobial agents on urogenital infections: the first edition. J Infect Chemother. 2011;17:579-94.","DOI":"10.1007\/s10156-010-0193-y"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma University specialized hospital, southwest Ethiopia. Ethiop J Health Sci. 2011;21:141-6.","DOI":"10.4314\/ejhs.v21i2.69055"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J. 2011;5:316-22.","DOI":"10.5489\/cuaj.687"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Blendon RJ, Schoen C, DesRoches CM, et al. Inequities in health care: a five-country survey. Health Aff (Millwood). 2002;21:182-91.","DOI":"10.1377\/hlthaff.21.3.182"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mishra B, Srivastava R, Agarwal J, et al. Behavioral and psychosocial risk factors associated with first and recurrent cystitis in Indian women: a case-control study. Indian J Community Med. 2016;41:27-33.","DOI":"10.4103\/0970-0218.170962"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Schoen C, Doty MM. Inequities in access to medical care in five countries: findings from the 2001 Commonwealth Fund International Health Policy Survey. Health Policy. 2004;67:309-22.","DOI":"10.1016\/j.healthpol.2003.09.006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Smith RD, Yago M, Millar M, et al. A macroeconomic approach to evaluating policies to contain antimicrobial resistance: a case study of methicillin-resistant <i>Staphylococcus aureus<\/i> (MRSA). Appl Health Econ Health Policy. 2006;5:55-65.","DOI":"10.2165\/00148365-200605010-00007"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis. 2002;8:347-54.","DOI":"10.3201\/eid0804.010312"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ramphal R, Ambrose PG. Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis. 2006;42:S164-72.","DOI":"10.1086\/500663"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lestari ES, Severin JA, Filius PM, et al. Antimicrobial resistance among commensal isolates of <i>Escherichia coli<\/i> and <i>Staphylococcus aureus<\/i> in the Indonesian population inside and outside hospitals. Eur J Clin Microbiol Infect Dis. 2007;27:45-51.","DOI":"10.1007\/s10096-007-0396-z"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yamamichi F, Shigemura K, Matsumoto M, et al. Relationship between urinary tract infection categorization and pathogens\u2019 antimicrobial susceptibilities. Urol Int. 2012;88:198-208.","DOI":"10.1159\/000334976"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Stamm AM, Bettacchi CJ. A comparison of 3 metrics to identify health care-associated infections. Am J Infect Control. 2012;40:688-91.","DOI":"10.1016\/j.ajic.2012.01.033"},{"key":"26","unstructured":"26. Coello R, Gastmeier P, de Boer AS. Surveillance of hospital-acquired infection in England, Germany, and The Netherlands: will international comparison of rates be possible? Infect Control Hosp Epidemiol. 2001;22:393-7."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113:suppl 1A, 14S-19S.","DOI":"10.1016\/S0002-9343(02)01055-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Perry HB, Zulliger R, Rogers MM. Community health workers in low-, middle-, and high-income countries: an overview of their history, recent evolution, and current effectiveness. Annu Rev Public Health. 2014;35:399-421.","DOI":"10.1146\/annurev-publhealth-032013-182354"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Jean SS, Coombs G, Ling T, et al. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: results from the study for monitoring antimicrobial resistance trends (SMART), 2010\u20132013. Int J Antimicrob Agents. 2016;47:328-34.","DOI":"10.1016\/j.ijantimicag.2016.01.008"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/71\/1\/71_JJID.2017.233\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T10:15:54Z","timestamp":1570270554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/71\/1\/71_JJID.2017.233\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2017.233","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}